Axonics Inc [AXNX] stock is trading at $69.60, up 0.49%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AXNX shares have gain 1.28% over the last week, with a monthly amount glided 1.24%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Axonics Inc [NASDAQ: AXNX] stock has seen the most recent analyst activity on January 09, 2024, when Wolfe Research downgraded its rating to a Peer Perform. Previously, Robert W. Baird started tracking the stock with Outperform rating on July 19, 2023, and set its price target to $69. On July 13, 2023, KeyBanc Capital Markets initiated with a Overweight rating and assigned a price target of $70 on the stock. CL King started tracking the stock assigning a Buy rating and suggested a price target of $75 on May 23, 2023. Mizuho initiated its recommendation with a Buy and recommended $75 as its price target on April 14, 2023. Needham upgraded its rating to Buy for this stock on March 24, 2023, but kept the price target unchanged to $71. In a note dated October 21, 2022, RBC Capital Mkts initiated an Outperform rating and provided a target price of $85 on this stock.
Axonics Inc [AXNX] stock has fluctuated between $48.30 and $69.68 over the past year. Currently, Wall Street analysts expect the stock to reach $71 within the next 12 months. Axonics Inc [NASDAQ: AXNX] shares were valued at $69.60 at the most recent close of the market. An investor can expect a potential return of 2.01% based on the average AXNX price forecast.
Analyzing the AXNX fundamentals
Axonics Inc [NASDAQ:AXNX] reported sales of 408.81M for the trailing twelve months, which represents a growth of 23.33%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at 0.0%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 69.33 points at the first support level, and at 69.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 69.77, and for the 2nd resistance point, it is at 69.95.
Ratios To Look Out For
For context, Axonics Inc’s Current Ratio is 8.96. In addition, the Quick Ratio stands at 7.11 and the Cash Ratio stands at 2.95. Considering the valuation of this stock, the price to sales ratio is 8.70, the price to book ratio is 5.52.
Transactions by insiders
Recent insider trading involved Noblett Karen, Chief Medical Officer, that happened on Jan 31 ’24 when 11288.0 shares were sold. EVP, Chief Mktg/Strtgy Officer, Woock John completed a deal on Jan 31 ’24 to sell 15899.0 shares. Meanwhile, Chief Commercial Officer Ford Alfred J Jr sold 16615.0 shares on Jan 31 ’24.
